Lietz, Nori Gerardo, Ricardo Andrade, and Sayiddah Fatima McCree. "Mubadala and EBX: To X or to X It?" Harvard Business School Case 217-065, March 2017. (Revised June 2019.) ...

Glasgow, Scotland - 18 March 2025. EnteroBiotix Limited ('EnteroBiotix'), a clinical-stage biopharmaceutical company focussed on developing best-in-class drugs for gut health, today announced positive ...

EBX-102-02 is a next-generation full-spectrum microbiome product that contains a high-diversity microbiome consortium, stabilised within a dried, off-white odourless powder. EBX-102-02 is designed to ...

EnteroBiotix Limited, a clinical-stage biopharmaceutical company focussed on developing best-in-class drugs for gut health, today announced positive initial results with EBX-102-02, the company’s next ...